secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pluri Inc. (PLUR)
CIK:        0001158780
Form:       8-K
Filed at:   2022-07-25T23:59:59+00:00
Accession:  0001213900-22-041096
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pluristem renamed Pluri Inc., ticker PLUR, pivots to multi-industry cell-based platform
--------------------------------------------------------------------------------

- Name change from Pluristem Therapeutics Inc. to Pluri Inc. effective July 26, 2022.
- Stock ticker symbol changes to 'PLUR' on Nasdaq Global Market.
- CEO Yaky Yanay outlines strategic pivot to cell-based technology for food-tech, agri-tech, and biologics.
- Commercialization strategy includes licensing and joint ventures ('Pluri focus units') with separate funding and management.
- Continues medical research but expands into non-medical cell-based solutions via partnerships.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158780/000121390022041096/0001213900-22-041096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158780/000121390022041096/ea163272-8k_pluriinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-041096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer